FEBS Letters
Tumour suppressor p53 inhibits hepatitis C virus replication by inducing E6AP‐mediated proteasomal degradation of the viral core protein
FEBS Letters, Volume 596, Issue 19, Page 2525-2537, October 2022.
FEBS Letters
The sphingolipid anteome: implications for evolution of the sphingolipid metabolic pathway
FEBS Letters, Volume 596, Issue 18, Page 2345-2363, September 2022.
FEBS Letters
Expanding the antiviral potential of the mosquito lipid‐transfer protein AEG12 against SARS‐CoV‐2 using hydrophobic antiviral ligands
FEBS Letters, Volume 596, Issue 19, Page 2555-2565, October 2022.
FEBS Letters
Profilin upregulation induces autophagy through stabilization of AMP‐activated protein kinase
FEBS Letters, Volume 596, Issue 14, Page 1765-1777, July 2022.
FEBS Letters
LIM protein Ajuba promotes liver cell proliferation through its involvement in DNA replication and DNA damage control
FEBS Letters, Volume 596, Issue 14, Page 1746-1764, July 2022.
FEBS Letters
Diacylglycerol kinase alleviates autophagic degradation of the endoplasmic reticulum in SPT10‐deficient yeast to enhance triterpene biosynthesis
FEBS Letters, Volume 596, Issue 14, Page 1778-1794, July 2022.
FEBS Letters
Membrane occupation and recognition nexus (MORN) motif controls protein localization and function
FEBS Letters, Volume 596, Issue 14, Page 1839-1850, July 2022.
FEBS Letters
Human induced pluripotent stem cells for studying mitochondrial diseases in the heart
FEBS Letters, Volume 596, Issue 14, Page 1735-1745, July 2022.
FEBS Letters
The activator/repressor Hap1 binds to the yeast eIF5A‐encoding gene TIF51A to adapt its expression to the mitochondrial functional status
FEBS Letters, Volume 596, Issue 14, Page 1809-1826, July 2022.
FEBS Letters
Tiki proteins are substrates of membrane‐type matrix metalloproteinases
FEBS Letters, Volume 596, Issue 14, Page 1851-1859, July 2022.